Clinical TrialApr 21, 2026, 10:01 AM
Disc Medicine to Present RALLY-MF Phase 2 Data at ASCO
AI Summary
Disc Medicine announced it will present data from its RALLY-MF Phase 2 trial of DISC-0974 for anemia of myelofibrosis at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 2, 2026. The company's CEO highlighted initial data showing "unprecedented" anemia response rates in this difficult-to-treat patient population. While the abstract will be published online on May 21, 2026, new data and analyses are reserved for the conference presentation, indicating potential for further positive updates.
Key Highlights
- Disc Medicine to present RALLY-MF Phase 2 trial data for DISC-0974.
- Presentation scheduled for June 2, 2026, at ASCO Annual Meeting.
- Initial data showed "unprecedented" anemia response rates in myelofibrosis.
- Abstract will be published online on May 21, 2026.